Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|15|7|711-718

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.15, Iss.7, 2014-09, pp. : 711-718

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population

By Scott Stuart A Edelmann Lisa Kornreich Ruth Erazo Monica Desnick Robert J

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 721-730

Future Medicine

Access to resources Recommend Favorite

Polymorphisms of CYP2C19 and CYP2D6 in Israeli Ethnic Groups

By Huai-Rong Luo

American Journal of PharmacoGenomics, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-401

Adis International

Access to resources Recommend Favorite

Influence of CYP2C9 and CYP2D6 Polymorphisms on the Pharmacokinetics of Nateglinide in Genotyped Healthy Volunteers

By Kirchheiner J.

Clinical Pharmacokinetics, Vol. 43, Iss. 4, 2004-01 ,pp. : 267-278

Adis International

Access to resources Recommend Favorite

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S. Galetin Aleksandra Hallifax David Houston J. Brian

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite

Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro

By Pan Yan Tiong Kai Abd-Rashid Badrul Ismail Zakiah Ismail Rusli Mak Joon Ong Chin

Journal of Natural Medicines, Vol. 68, Iss. 2, 2014-04 ,pp. : 402-406

Springer Publishing Company

Access to resources Recommend Favorite